Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3024% below fair value
$306.81+14.95 (+5.12%)
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker Adjusted Non-GAAP Gross Margin by Quarter
Adjusted Non-GAAP Gross Margin (%) (%)
Stryker Adjusted Non-GAAP Gross Margin: 65.4% in Q3 2026, up 0.4 pts from a year earlier.
Latest, Q3 2026
65.4%
Period ended Sep 30, 2026
Change on a year earlier
+0.4 pts
65.0% in Q3 2025
History
27 quarters
Since Q1 2020
Sources
27
Documents cited below
Where the Q3 2026 figure comes from
Reported in Stryker Form 8-K Non-GAAP Reconciliations.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Stryker Adjusted Non-GAAP Gross Margin (%), quarterly Q1 2020–Q3 2026 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/core-ng-gm
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.